LFST

LFST

USD

LifeStance Health Group Inc. Common Stock

$6.800+0.220 (3.343%)

Precio en Tiempo Real

Healthcare
Medical Care Facilities
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$6.580

Máximo

$6.865

Mínimo

$6.580

Volumen

0.00M

Fundamentos de la Empresa

Capitalización de Mercado

2.6B

Industria

Medical Care Facilities

País

United States

Estadísticas de Negociación

Volumen Promedio

1.83M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $4.64Actual $6.800Máximo $8.61

Informe de Análisis de IA

Última actualización: 5 may 2025
Generado por IAFuente de Datos: Yahoo Finance, Bloomberg, SEC

LFST: LifeStance Health Group Inc. Common Stock - What's Happening and What to Watch

Stock Symbol: LFST Generate Date: 2025-05-05 08:02:15

Alright, let's break down what's been going on with LifeStance Health (LFST) and what the latest info might suggest. This company is a big player in outpatient mental health care across the U.S., offering everything from therapy to psychiatric help, both online and in person. That's the core business we're looking at here.

Recent News Buzz: Analysts Are Talking

The news flow lately seems pretty positive, mainly thanks to Wall Street analysts starting to pay closer attention. We saw two separate firms, Keybanc and Canaccord Genuity, initiate coverage on LFST in early April.

  • Keybanc kicked things off with an "Overweight" rating and slapped a $9 price target on the stock.
  • Just a few days earlier, Canaccord Genuity started coverage with a "Buy" rating and an $8 price target.

Getting new analyst coverage, especially with positive ratings and price targets above where the stock has been trading, is generally seen as a good sign. It means these pros think the company has potential.

There's also news about LifeStance planning to host their first quarter 2025 earnings call on May 7th. This isn't positive or negative news on its own, but it's a really important date coming up. Earnings calls are when companies report how they actually performed, and that often causes big stock price moves depending on the results and future outlook they share.

Checking the Price Action: A Bumpy Ride Lately

Looking back at the last few months of trading data tells a story of its own. The stock was trading mostly between $7.80 and $8.10 back in early February. But then things took a turn. We saw a noticeable drop through late February and into March, with the price hitting lows around the $6.50 to $7.10 range.

Since that dip, the price has been kind of bouncing around, mostly staying within that lower range. The last recorded price on May 2nd was $6.80. So, while it's recovered a bit from the absolute lows, it's still well below where it was a few months ago. There have been days with higher trading volume mixed in, which can sometimes signal increased interest (either buying or selling).

What about the very near future? An AI prediction model suggests tiny movements for the next few days: basically flat today (0.00%), a slight dip tomorrow (-0.10%), and then a small bump the day after (+0.53%). These are very minor predicted changes, hinting at potential stability right before that key earnings call.

Putting It All Together: What Might This Mean?

So, we have positive signals from analysts initiating coverage with optimistic price targets, but the stock's actual price has been weak recently, trading much lower than those targets. The AI predicts minimal movement in the immediate short term.

Based on this mix, the situation seems to lean cautiously positive for those looking at the potential upside highlighted by analysts, but with a big question mark hanging over the upcoming earnings report. The recent price weakness could be seen by some as a chance to get in at a lower level compared to analyst targets.

  • Potential Entry Consideration: If you were considering this stock, the area around the recent closing price of $6.80 looks interesting. The recommendation data provided also points to potential entry points right around $6.80 to $6.84. This level is where the stock has been trading lately and aligns with some technical ideas about support.
  • Potential Exit/Stop-Loss Consideration: Managing risk is always key. The recommendation data suggests a potential stop-loss level at $6.13. This is below recent trading ranges and could be a point to consider cutting losses if the price continues to fall significantly. For taking profits, the recommendation data gives a near-term target of $6.95. Looking further out, those analyst targets of $8 and $9 (with an average around $9.14) represent potential upside if the company performs well and market sentiment improves.

Remember, the earnings call on May 7th is a major event that could change things quickly, regardless of recent trends or analyst opinions.

Important Note:

This analysis is based only on the data provided and is for informational purposes. It's not financial advice. Stock markets are unpredictable, and prices can go down as well as up. Always do your own thorough research or talk to a qualified financial advisor before making any investment decisions.

Noticias Relacionadas

GlobeNewswire

LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025

SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2025 earnings

Ver más
LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025
Analyst Upgrades

Keybanc Initiates Coverage On LifeStance Health Gr with Overweight Rating, Announces Price Target of $9

Keybanc analyst Steve Dechert initiates coverage on LifeStance Health Gr with a Overweight rating and announces Price Target of $9.

Ver más
Keybanc Initiates Coverage On LifeStance Health Gr with Overweight Rating, Announces Price Target of $9
Analyst Upgrades

Canaccord Genuity Initiates Coverage On LifeStance Health Gr with Buy Rating, Announces Price Target of $8

Canaccord Genuity analyst Richard Close initiates coverage on LifeStance Health Gr with a Buy rating and announces Price Target of $8.

Ver más
Canaccord Genuity Initiates Coverage On LifeStance Health Gr with Buy Rating, Announces Price Target of $8

Predicción de IABeta

Recomendación de IA

Alcista

Actualizado el: 5 may 2025, 07:32

BajistaNeutralAlcista

60.0% Confianza

Riesgo y Negociación

Nivel de Riesgo3/5
Riesgo Medio
Adecuado Para
Valor
Guía de Negociación

Punto de Entrada

$6.80

Toma de Ganancias

$6.95

Stop Loss

$6.13

Factores Clave

PDI 10.0 está por encima de MDI 8.7 con ADX 39.1, lo que sugiere una tendencia alcista
El precio actual está extremadamente cerca del nivel de soporte ($6.81), lo que sugiere una fuerte oportunidad de compra
El volumen de operaciones es 9.0 veces el promedio (19,616), lo que indica una presión de compra extremadamente fuerte
El MACD 0.0163 está por debajo de la línea de señal 0.0225, lo que indica un cruce bajista

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.